Projects per year
Fingerprint Dive into the research topics where Melissa LaBonte Wilson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 50 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 1 Active
Research Output
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
LaBonte Wilson, M., Ong, C. W., Armstrong, C., Waugh, D., Maxwell, P., O'Sullivan, J., Prise, K., Butterworth, K., Coulter, J., Walker, S., Oksana, L., Gallagher, R., Jain, S., Bristow, R. G. & Mills, I., 03 Jul 2020, In : NAR Cancer. 2, 3Research output: Contribution to journal › Article
Open Access
File
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists
McCann, C., Crawford, N., Majkut, J., Holohan, C., Armstrong, C., Maxwell, P., Ong, C. W., LaBonte Wilson, M., McDade, S., Waugh, D. & Longley, D., 22 Oct 2018, In : Cell, Death & Disease. 9, 1081, 13 p., 1081.Research output: Contribution to journal › Article
Open Access
File
4
Citations
(Scopus)
191
Downloads
(Pure)
Radio-resistance of PTEN-deficient prostate tumours is enhanced by treatment-induced chemokine signalling and is associated with biochemical recurrence and development of metastasis.
Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., Butterworth, K., Oksana, L., Berlingeri, S., LaBonte Wilson, M., Walker, S., O'Sullivan, J., Salto-Tellez, M., Jain, S., Mills, I., Illidge, T., Kennedy, R., Prise, K. & Waugh, D., 01 Aug 2018.Research output: Contribution to conference › Poster
The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer
Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Allen, W. L., Burkamp, F., Popovici, V., Jithesh, P. V., Isella, C., Labonte, M. J., Mills, I. G., Johnston, P. G. & Van Schaeybroeck, S., 26 Feb 2018, In : Molecular Cancer Therapeutics.Research output: Contribution to journal › Article
Open Access
File
4
Citations
(Scopus)
300
Downloads
(Pure)
Enhanced radio-sensitivity of PTEN-deficient prostate tumours mediated by inhibition of intrinsic and treatment-potentiated CXC-chemokine signaling
Armstrong, C., Coulter, J., Ong, C. W., Maxwell, P., LaBonte Wilson, M., Butterworth, K., Lyubomska, O., Berlingeri, S., Gallagher, R., Walker, S., O'Sullivan, J., Mills, I., Salto-Tellez, M., Illidge, T., Bristow, R. G., Kennedy, R., Prise, K. & Waugh, D., 2017.Research output: Contribution to conference › Poster
Prizes
MHLS Faculty Collaboration Seed Award
LaBonte Wilson, Melissa (Recipient), 2017
Prize: Prize (including medals and awards)
Activities
Early Career Researchers Forum Inaugural
Aidan Cole (Organiser), , Cristina Branco (Chair), , Seyed Mehdi Jafarnejad (Organiser), , Emma Allott (Organiser), , Stephen McMahon (Participant), , Karl Butterworth (Participant), , Emma Kerr (Participant), , Philip Dunne (Participant), , Adone Tielenius Kruythoff-Mohd Sarip (Participant), & Melissa LaBonte Wilson (Participant)
25 Nov 2019
Activity: Participating in or organising an event types › Participation in workshop, seminar, course
Enzalutamide-induced hypoxia attenuates response and promotes resistance in pre-clinical models of prostate cancer’
Melissa LaBonte Wilson (Advisor)
29 Apr 2017
Activity: Talk or presentation types › Invited talk
Association for Women in Science (External organisation)
Melissa LaBonte Wilson (Member)
2011 → …
Activity: Membership types › Membership of network
American Association for Cancer Research (External organisation)
Melissa LaBonte Wilson (Member)
2010 → …
Activity: Membership types › Membership of external research organisation
American Association for Cancer Research (External organisation)
Melissa LaBonte Wilson (Member)
2006 → …
Activity: Membership types › Membership of external research organisation